Margin Expansion and Guidance Raise Stand Out in H.B. Fuller's Q1 2026 Results
Profitability Improves Despite Volume Pressure
H.B. Fuller (NYSE:FUL) started fiscal 2026 with a clear message: disciplined execution and margin expansion are driving the story, even as market volumes soften. In Q1 2026, the adhesives specialist increased adjusted EBITDA by 4% to $119 million, pushed its adjusted EBITDA margin up by 90 basis points to 15.4%, and grew adjusted EPS by 6% year-over-year, reaching $0.57 per diluted share. This comes despite a 6.6% drop in organic revenue, as lower volumes more than offset a 0.6% net revenue lift from pricing actions.
Cost Controls, Pricing, and Supply Chain Actions Drive Margin Gains
The company’s strategic cost and supply chain initiatives were key. Adjusted gross margin climbed 170 basis points to 31.3%, fueled by restructuring savings, targeted raw material actions, and acquisition effects. Even with net revenue down 2.3% to $771 million, operating profit caught a lift from disciplined expense management—adjusted SG&A rose just 4% (to $176 million), with core expense trends showing slight improvement if one excludes the impact of M&A and FX.
Key Performance Table: Q1 2026 vs Q1 2025
| Metric | Q1 2026 | Q1 2025 | Year-on-Year Change |
|---|---|---|---|
| Net Revenue | $770.84M | $788.66M | -2.3% |
| Adjusted EBITDA | $118.70M | $114.36M | +4% |
| Adjusted EBITDA Margin | 15.4% | 14.5% | +0.9pp |
| Adjusted EPS (Diluted) | $0.57 | $0.54 | +6% |
| Adjusted Gross Margin | 31.3% | 29.6% | +1.7pp |
Guidance Raised on Revenue and Profit Targets
Management raised its full-year 2026 outlook, now expecting net revenue growth in the mid-single digits and organic revenue up in the low-single digits. Adjusted EBITDA is forecast between $645 million and $675 million. EPS guidance was also increased to a range of $4.55–$4.90 per diluted share. This confidence is underpinned by continued cost savings, supply chain management, and a recently announced strategic pricing initiative, aimed at offsetting ongoing geopolitical and inflation–related uncertainties.
Segment Performance: Engineering Adhesives Lead Margin Gains
Segment dynamics showed clear divergence:
| Segment | Net Revenue ($M) | Adj. EBITDA ($M) | Adj. EBITDA Margin |
|---|---|---|---|
| Hygiene, Health & Consumable Adhesives | 346.53 | 48.04 | 13.9% |
| Engineering Adhesives | 242.45 | 48.16 | 19.9% |
| Building Adhesive Solutions | 181.87 | 21.61 | 11.9% |
Engineering Adhesives stood out, posting nearly a full percentage point margin increase year-over-year, underscoring the value of mix improvement and operational efficiency. Hygiene and Health also improved margins, but Building Adhesive Solutions stayed roughly flat.
Debt and Cash Flow Metrics Show Conservative Management
Net debt ended the quarter at $1.97 billion, down $106 million year-on-year, bringing net debt to adjusted EBITDA down to 3.1x (versus 3.5x a year ago). Net working capital was up $20 million sequentially, but as a share of annualized revenues remained manageable at 19.0%. Cash from operations improved sharply by $49 million year-on-year to -$3.97 million, reflecting the usual seasonality and higher quarterly income. The company expects operational cash flow to strengthen further in the second half of 2026.
Takeaway: Operational Discipline Offsets Market Headwinds
Despite declining volumes and continued macro uncertainty, H.B. Fuller’s results and guidance upgrade show that disciplined cost management, supply chain flexibility, and targeted pricing can protect and enhance profitability. With further growth and cash flow improvement targeted for the back half of the year, the company appears well positioned to navigate ongoing supply and demand fluctuations—offering a case study in how margin focus can drive earnings resilience.
For a detailed discussion and webcast replay, visit H.B. Fuller Investor Relations.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI

